R
Robin Polt
Researcher at University of Arizona
Publications - 150
Citations - 3529
Robin Polt is an academic researcher from University of Arizona. The author has contributed to research in topics: Glycopeptide & Schiff base. The author has an hindex of 31, co-authored 147 publications receiving 3227 citations. Previous affiliations of Robin Polt include Columbia University & NASA Astrobiology Institute.
Papers
More filters
Journal ArticleDOI
A mild and efficient route to Schiff base derivatives of amino acids
Martin J. O'Donnell,Robin Polt +1 more
Journal ArticleDOI
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.
Robin Polt,Frank Porreca,Lajos Szabo,Edward J. Bilsky,Peg Davis,Thomas J. Abbruscato,Thomas P. Davis,R Harvath,Henry I. Yamamura,Victor J. Hruby +9 more
TL;DR: Intraperitoneally administered L-serinyl beta-D-glucoside analogues of [Met5]enkephalin (glycopeptides) have been shown to be transported across the blood-brain barrier to bind with targeted mu- and delta-opioid receptors in the mouse brain.
Journal ArticleDOI
Acidities of glycine Schiff bases and alkylation of their conjugate bases
Martin J. O'Donnell,William D. Bennett,William A. Bruder,William N. Jacobsen,Keith. Knuth,Brigitte. LeClef,Robin Polt,Frederick G. Bordwell,Susan Romberg Mrozack,Thomas A. Cripe +9 more
TL;DR: In this paper, the relative acidity decrease for Ph substitution points to a substantial increase in steric effect, as do the increases in pKa of 3.8 and 4.2 units observed for the replacement of hydrogen by Me and PhCH, respectively.
Journal ArticleDOI
Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin.
TL;DR: These peptide opiates bearing the pharmacophore H-Tyr-c[DCys-Gly-Phe-DCys]- were designed to probe the significance of the glycoside moiety and the carbohydrate-peptide linkage region in blood-brain barrier (BBB) transport, opiate receptor binding, and analgesia.
Journal ArticleDOI
Enkephalin Glycopeptide Analogues Produce Analgesia with Reduced Dependence Liability
Edward J. Bilsky,Richard D. Egleton,Scott A. Mitchell,Michael M. Palian,Peg Davis,Jason D. Huber,Heather Jones,Henry I. Yamamura,Jacqueline Janders,Thomas P. Davis,Frank Porreca,Victor J. Hruby,Robin Polt +12 more
TL;DR: The delta-selective glycosylated Leu-enkephalin amide 2, H(2)N-Tyr-D-Thr-Gly-Phe-Leu-Ser(beta-D -Glc)-CONH(2), produces analgesic effects similar to morphine, even when administered peripherally, yet possesses reduced dependence liability as indicated by naloxone-precipitated withdrawal studies.